España
India
Italia
대한민ęµ
日本
My Account
Benzinga Edge
Benzinga Research
Benzinga Pro
Login
Get Benzinga Pro
Data & APIs
Events
Premarket
Advertise
Contribute
España
India
Italia
대한민ęµ
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Screeners
Stock Screener
Top Momentum Stocks
Top Quality Stocks
Top Value Stocks
Top Growth Stocks
Recent
Markets
BTIG Research
BTIG: Crispr Could Be A Takeover Target For Vertex
Sell-Side Bullish On Uber As Quiet Period Ends
Domino's Hosted A Pizza Party With Investors—Here Are The Takeaways
Sell-Side Bullish On Uber As Quiet Period Ends
Domino's Hosted A Pizza Party With Investors—Here Are The Takeaways
BTIG Maintains Neutral Snap Thesis Ahead Of Q2 Report, But 'Patience Is Wearing Thin'
BTIG Raises Facebook Price Target By More Than 50%, Says Instagram Becoming 'Most Powerful, Valuable Mall In The World'
BTIG Maintains Neutral Snap Thesis Ahead Of Q2 Report, But 'Patience Is Wearing Thin'
|
BTIG Raises Facebook Price Target By More Than 50%, Says Instagram Becoming 'Most Powerful, Valuable Mall In The World'
|
A Peek Into The Markets: U.S. Stock Futures Tumble Ahead Of Economic Reports
|
Analyst: Why Jim Dolan Could Sell The New York Knicks
|
Read More...
BTIG Research Recent News
Chipotle's Menu Price Increases Will Likely Expand In Coming Months
|
Facebook's Secular Trends Toward Mobile, Accelerating Shift Of Ad Dollars
|
A Peek Into The Markets: U.S. Stock Futures Gain; All Eyes On Jobs Report
|
A Peek Into The Markets: U.S. Stock Futures Edge Higher Ahead Of Earnings
|
Starbucks Remains One Of The 'Most Compelling, Forward-Thinking Concepts'
|
BTIG Research Initiates Lumos Networks At Buy, Calls Co. A Small-Cap Play On High-Speed Fiber Expansion
|
BTIG Research Upgrades Alere To Buy, Says 10-K Filing Offers 'Fundamental Opportunity'
|
8 Netflix Investor Concerns Heading Into Q2 Earnings Report
|
Yum's Guidance Increase Makes Up For Weak Q2 Sales, Says BTIG
|
Seagate Has To Prove Itself Over 6-9 Months Says BTIG; Reiterates Buy
|
Boingo Wireless Initiated At Sell By BTIG Research
|
Analysts Give Healthcare Sector A Clean Bill Of Health
|
BTIG Still Buying Relypsa As May Prescription Trends Show Steady Veltassa Increases
|
Medtronic's Spine Division Continues To Lag The Market
|
BTIG Starts MacroGenics At Buy, Sees 63% Upside
|
Intuitive Surgical Shares Downgraded To Neutral At BTIG
|
Hedge Fund Manager: Disney's CEO Needs To 'Talk Straight'
|
The Downgrade That Sent Disney Shares Lower
|
BTIG Research Initiates Teva Pharmaceutical At Buy
|
BTIG Research Downgrades Assured Guaranty To Neutral
|
BTIG Research Initiates Crown Castle International With Buy
|
BTIG Research Upgrades FactSet Research Systems To Neutral
|
US Stock Futures Up; All Eyes On Fed Decision
|